BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• Drug Development

  Selvita Announces First Patient Dosed in Phase 1b Study of CDK8 Inhibitor SEL120 in the Treatment of Acute Myeloid Leukemia or High Risk Myelodysplastic Syndrome

  Selvita announced that the first patient enrolled in the Phase 1b study of company’s selective CDK8 inhibitor, SEL120, has received the first dose.

  September 6, 2019

   · 

  5 min read
• Business

  Step Pharma Appoints Seasoned Drug Developer Dr. Andrew Parker as Chief Executive Officer

  Step Pharma announced the appointment of Andrew Parker, Ph.D., as Chief Executive Officer and member of the Supervisory Board.

  September 6, 2019

   · 

  3 min read
• Policy

  /R E P E A T -- Media Advisory - Minister Ng to highlight investments to scale up Canadian health technology companies/

  The Honourable Mary Ng, Minister of Small Business and Export Promotion, will attend the Toronto Global Forum, where she will highlight investments to scale up Canadian health technology companies.

  September 6, 2019

   · 

  1 min read